Form 8-K - Current report:
SEC Accession No. 0001171843-25-002158
Filing Date
2025-04-11
Accepted
2025-04-11 16:31:15
Documents
14
Period of Report
2025-04-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_041025.htm   iXBRL 8-K 30501
2 EXHIBIT 16.1 exh_161.htm EX-16.1 3920
  Complete submission text file 0001171843-25-002158.txt   209669

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bysi-20250408.xsd EX-101.SCH 3044
4 XBRL LABEL FILE bysi-20250408_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE bysi-20250408_pre.xml EX-101.PRE 22378
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_041025_htm.xml XML 3695
Mailing Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38024 | Film No.: 25832502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)